✦ LIBER ✦

Expectant therapy for clinical stage A nonseminomatous germ-cell tsticular cancer? Maybe

✍ Scribed by M. A. S. Jewett; J. G. Herman; J. F. G. Sturgeon; R. H. Comisarow; R. E. Alison; M. K. Gospodarowicz

Publisher: Springer-Verlag
Year: 1984
Tongue: English
Weight: 189 KB
Volume: 2
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf00326935

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expectant therapy for clinical stage A n

Expectant therapy for clinical stage A nonseminomatous germ-cell tumors of the testis? No

✍ Gary Lieskovsky; Donald G. Skinner 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 488 KB

Expectant therapy for clinical stage A n

Expectant therapy for clinical stage A nonseminomatous germ-cell cancers of the testis? A qualified “Yes”

✍ Derek Raghavan 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 483 KB

Prognostic risk factors that identify pa

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

✍ Axel Heidenreich; Isabell A. Sesterhenn; F. Kash Mostofi; Judd W. Moul 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Background: The purpose of this study was to develop a reliable model to identify clinical stage i nonseminomatous germ cell tumors (nsgcts) associated with low risk or high risk for occult retroperitoneal metastasis, so that the model could be used to customize the therapeutic approach for pati

Immunohistochemical assessment of tumor

Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage a nonseminomatous testicular germ cell tumor at low risk for occult metastasis

✍ Peter Albers; Greg A. Miller; Attilio Orazi; Thomas M. Ulbright; Jutta Albers; J 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB